SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC — Stella

Recruiting

Back to Advanced Nasopharyngeal Carcinoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Key details

Phase

Safety & dosing

Sponsor

Zhejiang Cancer Hospital

Enrollment target

~37 participants

Started

September 2022

Primary completion

October 2026

Age range

18 Years – 75 Years

Last updated December 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov